Laura DiGiovanni is Director, Study Operations in the Patient-Centered Outcomes Center of Excellence located in Pharmerit’s Bethesda office. Her expertise includes operational planning, development of project tools, and resource management. Laura has therapeutic experience in the following areas: Hereditary Cancer Susceptibility Syndromes, Oncology, ALS, and Dementia, working on both North American and global research initiatives.
Prior to joining Pharmerit, Laura worked within the Real World Solutions department of a leading CRO, managing the day-to-day operations of global interventional Phase III/IV clinical trials from study award through close-out. The majority of her career was spent at the University of Pennsylvania managing design, recruitment, execution, and publication of non-interventional studies in oncology. Laura started her career at a large pharmaceutical company. The combined experience at a pharmaceutical company, in academia, and at a CRO will enable her to successfully lead the study operations team with a keen eye towards site recruitment and management. Laura earned a Bachelor of Arts degree from Villanova University, and then a Master of Liberal Arts degree from the University of Pennsylvania.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.